Form 4 for TXMD TherapeuticsMD, Inc.
Accepted 2022-03-15 00:00:00 ET · period of report 2022-03-14 · accession 0001209191-22-018682 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-03-15 | 2022-03-14 | TXMD | Walker Marlan D | GC | M - OptEx | — | +230.0K | 258.9K | +796% | — |
| D | 2022-03-15 | 2022-03-14 | TXMD | Walker Marlan D | GC | M - OptEx | $0.00 | -230.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-03-14 | M | A | 230,000 | — | 258,908 | D | — | — | (F1) On March 14, 2022, the reporting person received 230,000 shares of issuer common stock in settlement of restricted stock units (RSUs), which vested on December 13, 2021. |
| 2 | Derivative | Restricted Stock Units | 2022-03-14 | M | D | 230,000 | $0.00 | 0 | D | $0.00 · — to — | 230,000 Common Stock | (F2) Each RSU represents a contingent right to receive one share of issuer common stock upon settlement. (F1) On March 14, 2022, the reporting person received 230,000 shares of issuer common stock in settlement of restricted stock units (RSUs), which vested on December 13, 2021. (F3) The RSUs vested on December 13, 2021. |